Composition
- Active ingredients
- ALENDRONATE SODIUM EQ 70MG BASE/75ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ALENDRONATE SODIUM EQ 70MG BASE · TabletNDA020560-005 · Prescription
- ALENDRONATE SODIUM EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020560-003 · Discontinued
- ALENDRONATE SODIUM EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020560-001 · Discontinued
- ALENDRONATE SODIUM EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020560-004 · Discontinued
- ALENDRONATE SODIUM EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020560-002 · Discontinued
- ALENDRONATE SODIUM EQ 70MG BASE/75ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021575.
At a glance
- Brand name
- Fosamax
- Active substance
- alendronate sodium
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Merck
- Status
- Discontinued
- FDA approval
- 17 Sept 2003
- Application
- NDA021575-001